Håkan Widner
21 – 30 of 151
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Wilson disease: Acute dystonia during treatment with SSRI or SNRI
(2016) XXI World Congress on Parkinson's Disease and Related Disorders In Parkinsonism and Related Disorders 22(Suppl 2). p.140-141
- Contribution to journal › Published meeting abstract
-
Mark
Levodopa-carbidopa intestinal gel (LCIG) treatment in routine care of patients with advanced Parkinson's disease : An open-label prospective observational study of effectiveness, tolerability and healthcare costs
- Contribution to journal › Article
-
Mark
A genome-wide association study in multiple system atrophy
- Contribution to journal › Article
-
Mark
Increased serotonin-to-dopamine transporter ratios in Parkinson disease dyskinesias: a longitudinal study
- Contribution to conference › Abstract
-
Mark
Imaging nigrostriatal circuitry with 11C-PE2I PET and Neuromelanin-sensitive MR in Parkinson’s disease
- Contribution to conference › Abstract
-
Mark
Aberrant nigral diffusion in Parkinson's disease : A longitudinal diffusion tensor imaging study
- Contribution to journal › Article
- 2015
-
Mark
Validity and Responsiveness of At-Home Touch Screen Assessments in Advanced Parkinson's Disease
- Contribution to journal › Article
-
Mark
Disease-specific structural changes in thalamus and dentatorubrothalamic tract in progressive supranuclear palsy.
- Contribution to journal › Article
-
Mark
Memantine and reduced time with dyskinesia in Parkinson's Disease.
(2015) In Acta Neurologica Scandinavica
- Contribution to journal › Article
-
Mark
Eltoprazine counteracts l-DOPA-induced dyskinesias in Parkinson's disease: a dose-finding study.
- Contribution to journal › Article
